医学
原发性醛固酮增多症
队列
内科学
醛固酮
逻辑回归
医疗
盐皮质激素受体
队列研究
回顾性队列研究
疾病
血浆肾素活性
观察研究
儿科
内分泌学
醛固酮增多症
盐皮质激素
低钾血症
蛋白尿
作者
Jun Yang,Jessica Goi,Jacopo Burrello,Martín Reincke,Christian Adolf,Denise Brüdgam,Qifu Li,Ying Song,Jinbo Hu,Shumin Yang,Fumitoshi Satoh,Yoshikiyo Ono,Renata Libianto,Michael Stowasser,Nanfang Li,Qing Zhu,Namki Hong,Drishya Nayak,Troy Hai Kiat Puar,Vin‐Cent Wu
出处
期刊:Hypertension
[Lippincott Williams & Wilkins]
日期:2026-07-22
卷期号:83 (9): e27431-e27431
被引量:1
标识
DOI:10.1161/hypertensionaha.126.27431
摘要
BACKGROUND: Primary aldosteronism (PA) is a common and treatable cause of hypertension, yet data on the durability of medical treatment response beyond the first year are limited. Using the PA medical treatment outcomes framework, we evaluated long-term biochemical and clinical outcomes and factors associated with treatment response. METHODS: We conducted an international, multicenter, observational cohort study across 27 centers on 4 continents. Adults with PA treated with mineralocorticoid receptor antagonists and/or epithelial sodium channel blockers between 2016 and 2021 were included if follow-up data were available at ≥12 months. Biochemical and clinical responses were classified as complete, partial, or absent using PA medical treatment outcomes criteria. Ordinal logistic regression identified determinants of a favorable treatment response. RESULTS: The cohort included 1292 patients (47.5% women, mean age 52 years) with a median follow-up of 34 months (interquartile range, 21-51). At ≥12 months, 58.3% achieved a complete biochemical response, and 20.8% achieved a complete clinical response, with only 5% showing no response. Determinants of a favorable biochemical response included lower aldosterone and lateralization index, and higher renin and potassium levels at baseline. In those taking spironolactone, a higher daily dose was also associated with a favorable biochemical response. Determinants of a favorable clinical response included female sex, lower body mass index, shorter duration of hypertension, and absence of hypertension-mediated organ damage. CONCLUSIONS: Targeted medical therapy for PA can deliver sustained biochemical and clinical benefits. Early disease detection and adequate dose titration are highly actionable determinants of long-term treatment success.
科研通智能强力驱动
Strongly Powered by AbleSci AI